Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
Virendra Rambiritch,1 Poobalan Naidoo,2 Goonaseelan Pillai3 1Pharmacology Department, University of KwaZulu-Natal, Durban, 2Department of Internal Medicine, RK Khan Regional Hospital, Chatsworth, South Africa; 3Scientific Capability Development, Novartis Pharma AG, Basel, Switzerland Aim: To determi...
Saved in:
Main Authors: | Rambiritch V (Author), Naidoo P (Author), Pillai G (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects
by: Rambiritch V, et al.
Published: (2016) -
Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study
by: Rambiritch V, et al.
Published: (2014) -
Pharmacokinetics and Pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat
by: María R León-Reyes, et al.
Published: (2016) -
Population pharmacokinetics and pharmacodynamics of nasal glucagon in patients with type 1 or 2 diabetes
by: Douglas E. James, et al.
Published: (2024) -
Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus
by: Yuqing Li, et al.
Published: (2012)